140 related articles for article (PubMed ID: 28898712)
1. Inhibition of the lytic cycle of Kaposi's sarcoma-associated herpesvirus by cohesin factors following de novo infection.
Toth Z; Smindak RJ; Papp B
Virology; 2017 Dec; 512():25-33. PubMed ID: 28898712
[TBL] [Abstract][Full Text] [Related]
2. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
Li D; Mosbruger T; Verma D; Swaminathan S
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380
[TBL] [Abstract][Full Text] [Related]
3. Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency.
Chen HS; Wikramasinghe P; Showe L; Lieberman PM
J Virol; 2012 Sep; 86(17):9454-64. PubMed ID: 22740398
[TBL] [Abstract][Full Text] [Related]
4. CTCF and Rad21 act as host cell restriction factors for Kaposi's sarcoma-associated herpesvirus (KSHV) lytic replication by modulating viral gene transcription.
Li DJ; Verma D; Mosbruger T; Swaminathan S
PLoS Pathog; 2014 Jan; 10(1):e1003880. PubMed ID: 24415941
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions.
Kang H; Lieberman PM
J Virol; 2009 Jun; 83(12):6199-210. PubMed ID: 19369356
[TBL] [Abstract][Full Text] [Related]
6. Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation.
Kang H; Wiedmer A; Yuan Y; Robertson E; Lieberman PM
PLoS Pathog; 2011 Aug; 7(8):e1002140. PubMed ID: 21876668
[TBL] [Abstract][Full Text] [Related]
7. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
Naik NG; Nguyen TH; Roberts L; Fischer LT; Glickman K; Golas G; Papp B; Toth Z
PLoS Pathog; 2020 Jan; 16(1):e1008268. PubMed ID: 31923286
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
10. Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection.
Toth Z; Brulois K; Lee HR; Izumiya Y; Tepper C; Kung HJ; Jung JU
PLoS Pathog; 2013; 9(12):e1003813. PubMed ID: 24367262
[TBL] [Abstract][Full Text] [Related]
11. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
Liang Y; Ganem D
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
[TBL] [Abstract][Full Text] [Related]
12. PRC1-independent binding and activity of RYBP on the KSHV genome during de novo infection.
Lee SC; Toth Z
PLoS Pathog; 2022 Aug; 18(8):e1010801. PubMed ID: 36026503
[TBL] [Abstract][Full Text] [Related]
13. Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase.
Chang PC; Fitzgerald LD; Van Geelen A; Izumiya Y; Ellison TJ; Wang DH; Ann DK; Luciw PA; Kung HJ
Cancer Res; 2009 Jul; 69(14):5681-9. PubMed ID: 19584288
[TBL] [Abstract][Full Text] [Related]
14. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
[TBL] [Abstract][Full Text] [Related]
15. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
16. Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.
Gong D; Dai X; Xiao Y; Du Y; Chapa TJ; Johnson JR; Li X; Krogan NJ; Deng H; Wu TT; Sun R
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515293
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
19. Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators.
Stedman W; Kang H; Lin S; Kissil JL; Bartolomei MS; Lieberman PM
EMBO J; 2008 Feb; 27(4):654-66. PubMed ID: 18219272
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic analysis of KSHV latent and lytic genomes.
Toth Z; Maglinte DT; Lee SH; Lee HR; Wong LY; Brulois KF; Lee S; Buckley JD; Laird PW; Marquez VE; Jung JU
PLoS Pathog; 2010 Jul; 6(7):e1001013. PubMed ID: 20661424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
